The limited information on micro-mechanism of sulfamethoxazole (SMX) metabolism and antibiotics resistance genes (ARGs) behaviors within membrane-aerated biofilm reactor (MABR) blocked the application of MABR in treating antibiotics containing wastewater. In this work, SMX metabolism and the changes of ARGs were investigated in MABR during 0.0–0.7 mg/L SMX. The system achieved a 92.3% SMX removal at 0.7 mg/LSMX, leading to the formation of 17 lower toxic metabolites, which indicated the robust SMX biodegradation capability of MABR. The metabolic pathways of SMX in MABR were first elucidated, revealing key processes including isoxazole ring opening (primarily in anaerobic zones), aniline hydroxylation, and cleavage of the S-N bond in the sulfonyl group. Microbial analysis revealed the involvement of multiple microbes in SMX biodegradation, and among these, sulfate-reducing bacteria (SRB; Desulfovibrio, Desulforhopalus, Desulfomicrobium) facilitated the isoxazole ring opening in the anaerobic zone, while Rhizobium and Chryseobacterium contributed to ipso-hydroxylation and cleavage of the -C-S-N bond in SMX, respectively. Furthermore, the slower accumulation of ARGs under SMX conditions was primarily attributed to the enhanced efflux pump activity, antibiotic target replacement mechanisms, and secretion of extracellular polymeric substances (EPS), suggesting the potential of MABR to inhibit ARG proliferation. Our research filled the knowledge gap in the micro-mechanism of SMX metabolism and ARGs fate within MABR processing SMX-containing wastewater, laying a theoretical foundation for the broader application of MABR in practical engineering.
Read full abstract